Pyoderma gangrenosum-like skin changes after subcutaneous administration of low molecular weight heparin.
In the present report, we would like to comment a case of patient with diabetes mellitus type 2 manifesting the rare complication of heparin subcutaneous administration in a form of pyoderma gangrenosum-like skin changes which were induced probably by an immune-modulating activity of heparin.
Department of Pathophysiology; Wroclaw Medical University; Wroclaw, Poland.
Małgorzata
M
Sobieszczańska
Department of Internal Diseases; Opole Voivodship Hospital; Opole, Poland.
Sławomir
S
Tubek
Department of Dermatology; Opole Voivodship Hospital; Opole, Poland.
Ilona
I
Kura
D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans; D007279:Injections, Subcutaneous; D008875:Middle Aged; D017511:Pyoderma Gangrenosum / Q000139:chemically induced*; D012867:Skin / Q000473:pathology*
D006495:Heparin, Low-Molecular-Weight
gangrenosum; injection; low-weight heparin; pyoderma